Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?-Reference-Cited by-同舟云学术

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

Published:2018-03 Issue:3 Volume:68 Page:597-600
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Di Maio Velia Chiara,Cento Valeria^ORCID,Aragri Marianna,Paolucci Stefania,Pollicino Teresa,Coppola Nicola,Bruzzone Bianca,Ghisetti Valeria,Zazzi Maurizio,Brunetto Maurizia,Bertoli Ada,Barbaliscia Silvia,Galli Silvia,Gennari William,Baldanti Fausto,Raimondo Giovanni,Perno Carlo Federico,Ceccherini-Silberstein Francesca,Andreone Pietro,Andreoni Massimo,Angelico Mario,Babudieri Sergio,Barbarini Giorgio,Boccaccio Vincenzo,Boglione Lucio,Bolis Matteo,Bonora Stefano,Borghi Vanni,Brancaccio Giuseppina,Bruno Savino,Cacciatore Pierluigi,Calvaruso Vincenza,Caporaso Nicola,Ciaccio Antonio,Ciancio Alessia,Colombatto Piero,Cozzolongo Raffaele,Craxì Antonio,D'Ambrosio Cecilia,D'Ettorre Gabriella,De Luca Andrea,Di Biagio Antonio,Di Perri Giovanni,Francioso Simona,Gaeta Giovanni Battista,Giorgini Alessia,Grieco Antonio,Gubertini Guido,Gulminetti Roberto,Lambiase Lara,Lenci Ilaria,Lichtner Miriam,Maida Ivana,Marenco Simona,Marinaro Letizia,Maserati Renato,Masetti Chiara,Melis Michela,Meregalli Elisa,Micheli Valeria,Morisco Filomena,Niero Fosca,Nicolini Laura Ambra,Palitti Valeria Pace,Paoloni Maurizio,Parruti Giustino,Pasquazzi Caterina,Pellicelli Adriano,Polilli Ennio,Ponti Maria Laura,Puoti Massimo,Rendina Maria,Rizzardini Giuliano,Rossetti Barbara,Ruggiero Tina,Sangiovanni Vincenzo,Starace Mario,Sticchi Laura,Tarquini Pierluigi,Toniutto Pierluigi,Vullo Vincenzo

Publisher

Elsevier BV

Subject

Hepatology

Reference10 articles.

1. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses;Welzel;J Hepatol,2017

2. The importance of resistance to direct antiviral drugs in HCV infection in clinical practice;Sarrazin;J Hepatol,2016

3. Virus resistance to direct-acting antiviral drugs in interferon-free regimens;Pawlotsky;Gastroenterology,2016

4. EASL recommendations on treatment of hepatitis C 2016;J Hepatol,2017

5. Hepatitis C Guidance: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C. http://www.hcvguidelines.org. Accessed May 26, 2017.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of SOF/VEL containing rescue therapy in treating chronic HCV-GT4 patients previously failed NS5A inhibitors-based DAAs;Egyptian Liver Journal;2024-03-11

2. Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure;Journal of Hepatology;2023-01

3. Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals;Frontiers in Pharmacology;2022-04-27

4. HCV-positive kidney transplant patients treated with direct-acting antivirals maintain stable medium-term graft function despite persistent reduction in tacrolimus trough levels;Therapeutic Advances in Chronic Disease;2022-01

5. The Role of RASs /RVs in the Current Management of HCV;Viruses;2021-10-18